scanance.
Sign inGet Premium
NH

National Health Investors, Inc.

NHIReal EstateNASDAQ

REIT - Healthcare Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot
MA150-4.82%
$79.14

Price below medium-term moving average.

MA200-3.46%
$78.02

Below long-term trend line.

RSI-14neutral
42.3

Balanced. Not overbought, not oversold.

MACDpositive
+0.3200

Histogram positive — upward momentum.

Financials · Annual
Revenue
$375.6M
+12.1% YoY
Net Income
$142.2M
+3.0% YoY
EBITDA
$275.7M
+4.3% YoY
Free Cash Flow
$208.0M

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About National Health Investors, Inc.

Headquartered within the real estate sector, National Health Investors, Inc. focuses on REIT - Healthcare Facilities services and products. National Health Investors, Inc. is a self-managed real estate investment trust specializing in sale-leaseback, joint venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical facility. The $3.65B market capitalization puts NHI squarely in mid-cap range for its industry. NHI's portfolio consists of independent living facilities, assisted living and memory care communities, entrance-fee retirement communities, senior living campuses, skilled nursing facilities and specialty hospitals.

Key stats
Market Cap$3.65B
P/E (TTM)24.14
Fwd P/E20.79
EPS$3.10
Beta0.58
52W Change+3.9%
Dividend Yield4.89%
ROE9.9%
Analysis

National Health Investors, Inc. carries $1.52B in total debt against $113.4M in cash reserves — debt is roughly 13.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $208.0M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 9.9% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.4% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $278.2M (2022) to $375.6M (2025), reflecting a 35% increase over the period.

NHI's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. National Health Investors, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for National Health Investors, Inc. and its sector.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms